Adrastea Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADRASTEA PHARMA, and what generic and branded alternatives to ADRASTEA PHARMA drugs are available?
ADRASTEA PHARMA has three approved drugs.
Drugs and US Patents for Adrastea Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adrastea Pharma | LEVETIRACETAM | levetiracetam | INJECTABLE;INTRAVENOUS | 091485-001 | Aug 5, 2011 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Adrastea Pharma | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 063000-001 | Sep 30, 1994 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Adrastea Pharma | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | INJECTABLE;INJECTION | 203110-001 | Jun 29, 2015 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.